High Risk of Tumor Lysis Syndrome in Symptomatic Patients with Multiple Myeloma with Renal Dysfunction Treated with Bortezomib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High Risk of Tumor Lysis Syndrome in Symptomatic Patients with Multiple Myeloma with Renal Dysfunction Treated with Bortezomib

Published:2016-12-01 Issue:12 Volume:36 Page:6655-6662
ISSN:0250-7005
Container-title:Anticancer Research
language:
Short-container-title:AR

Author:

OIWA KANA,MORITA MIHOKO,KISHI SHINJI,OKURA MIYUKI,TASAKI TOSHIKI,MATSUDA YASUFUMI,TAI KATSUNORI,HOSONO NAOKO,UEDA TAKANORI,YAMAUCHI TAKAHIRO

Publisher

Anticancer Research USA Inc.

Subject

Cancer Research,Oncology,General Medicine

Link

http://ar.iiarjournals.org/content/36/12/6655.full.pdf

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor Lysis Syndrome;Textbook of Palliative Care;2024

2. Risk Factors Leading to Tumor Lysis Syndrome in Chemotherapy for Multiple Myeloma;Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2023-07-10

3. Incidence, clinical characteristics and prognosis of tumor lysis syndrome following B-cell maturation antigen-targeted chimeric antigen receptor-T cell therapy in relapsed/refractory multiple myeloma;Frontiers in Immunology;2023-05-04

4. Management of Renal Failure in Multiple Myeloma;Recent Updates on Multiple Myeloma;2023-03-15

5. Carfilzomib-Induced Tumor Lysis Syndrome and Biventricular Heart Failure in a Patient With Multiple Myeloma;Cureus;2023-01-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP